<DOC>
	<DOCNO>NCT01838044</DOCNO>
	<brief_summary>The purpose study determine treatment celecoxib pregabalin together would prove effective relief pain treatment celecoxib alone people chronic low back pain probable neuropathic component .</brief_summary>
	<brief_title>Efficacy Safety Study Celecoxib Pregabalin Compared With Celecoxib Monotherapy , Patients With Chronic Low Back Pain Having Neuropathic Component</brief_title>
	<detailed_description>The primary objective evaluate efficacy concomitant use pregabalin celecoxib compare celecoxib monotherapy symptomatic relief pain patient chronic low back pain probable neuropathic component . The secondary objective : - Demonstrate additional benefit add pregabalin celecoxib monotherapy . - To evaluate concomitant use pregabalin celecoxib compare celecoxib monotherapy set patient report measure ( sleep , depression , anxiety , impact pain daily function , patient 's global impression change patient 's perception treatment ) . - To evaluate safety tolerability celecoxib concomitant administration pregabalin celecoxib .</detailed_description>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Subjects must Chronic low back pain high probability significant neuropathic component 4 year less ( less 3 month ) Subjects must generally good health , except presence chronic low back pain neuropathic component . Subjects must literate ability ( unaided ) understand use interactive voice response system ( IVRS ) , daily access telephone internet order complete IVRS assessment day , perform telephone web visit complete require assessments/forms Subjects past history surgery chronic low back pain . Subjects past history failure pregabalin treatment and/or intolerance associate pregabalin gabapentin . Subjects past history intolerance associate celecoxib know hypersensitivity celecoxib . Patients anticipated need treatment opioid analgesic , antiepileptic medication , SNRI antidepressants tricyclic antidepressant alleviate pain course study . Patients chronic low back pain neuropathic component 4 year . Patients neurologic disorder unrelated low back pain may confuse confound assessment neuropathic pain ( eg , primary secondary nerve disease ) . Subjects consider risk suicide selfharm base investigator judgment and/or detail risk assessment . Use prohibit medication absence appropriate washout period . Patients severe pain associated condition chronic low back pain neuropathic component may confound assessment selfevaluation pain due chronic low back pain . Patients diabetes poor glycemic control ( HbA1c &gt; 8 % ) . Patients clinically significant unstable medical psychiatric condition laboratory abnormality , opinion investigator , would compromise participation study Patients participate previous clinical trial pregabalin participate 2 previous clinical trial pain related chronic low back pain . Patients likely require surgery course study ( except minor surgery , eg , skin condition ) Patients history Substance Abuse define DSMIVTR diagnostic criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>